VIENNA – Pooled analysis of data from three controlled trials provides further evidence to support the use of vitamin E in the treatment of nonalcoh... More »
VIENNA – The new European recommendations for diagnosing and treating hepatitis C infection highlight the paradox gripping the field: Safe and poten... More »
VIENNA – The oral hypoglycemic liraglutide produced significant histologic resolution of nonalcoholic steatohepatitis after nearly a year of treatme... More »
VIENNA – Nonalcoholic fatty liver disease often goes overlooked as a cause of liver cancer despite its increasing role as a major driver of hepatoce... More »
Individuals with biopsy-confirmed celiac disease have more than double the risk of receiving a diagnosis of neuropathy when compared with the general ... More »
VIENNA – Delaying hepatitis C virus (HVC) treatment can have a detrimental effect on the outcomes of some patients, according to the results of a la... More »
VIENNA – More than 75% of patients with decompensated cirrhosis due to chronic hepatitis C virus (HCV) infection achieved a sustained virologic resp... More »
VIENNA – The early results of a prospective, multicenter study show a high rate of hepatic focal lesions, further supporting liver cancer screening ... More »
VIENNA – Major cardiovascular (CV) events are significantly increased in hospital patients who are infected with the hepatitis C virus (HCV) versus ... More »
Treatment with the spores of nontoxigenic Clostridium difficile is well tolerated, and successful colonization of the gastrointestinal tract is associ... More »
